X 3 2 Pill: white, capsule/oblong, 22mm
The pill with imprint X 3 2 (White, Capsule/Oblong, 22mm) has been identified as Amoxicillin and Clavulanate Potassium 875 mg / 125 mg and is used for Bacterial Infection, Bronchitis, Aspiration Pneumonia, Bronchiectasis, and Febrile Neutropenia. It belongs to the drug class penicillins/beta-lactamase inhibitors and is not a controlled substance.
Images for X 3 2
Amoxicillin and Clavulanate Potassium
- Imprint
- X 3 2
- Strength
- 875 mg / 125 mg
- Color
- White (white to off-white)
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Penicillins/beta-lactamase inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Chartwell RX, LLC
- Inactive Ingredients
-
silicon dioxide,
crospovidone,
hypromellose 2910 (5 mPa.s),
hypromellose 2910 (15000 mPa.s),
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol 4000,
polyethylene glycol 6000,
sodium starch glycolate type A potato,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 16714-0297 | NorthStar Rx LLC |
| 65862-0503 | Aurobindo Pharma Limited |
Related images for "X 3 2"
More about amoxicillin / clavulanate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (916)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: penicillins/beta-lactamase inhibitors
- En español
Patient resources
Other brands
Augmentin, Amoclan, Augmentin ES-600, Augmentin XR
Professional resources
- Amoxicillin/Clavulanate monograph
- Amoxicillin and Clavulanate Chewable (FDA)
- Amoxicillin and Clavulanate ER Tablets (FDA)
- Amoxicillin and Clavulanate Oral Suspension (FDA)
- Amoxicillin and Clavulanate Tablets (FDA)
Other brands
Augmentin, Amoclan, Augmentin ES-600, Augmentin XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.